Drug Shortage Report for ERTAPENEM FOR INJECTION
Report ID | 154473 |
Drug Identification Number | 02496127 |
Brand name | ERTAPENEM FOR INJECTION |
Common or Proper name | Ertapenem for Injection, 1g SD Vial 20mL |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | ERTAPENEM |
Strength(s) | 1G |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAMUSCULAR |
Packaging size | 20mL |
ATC code | J01DH |
ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-05-02 |
Estimated end date | Unknown |
Actual end date | 2022-09-20 |
Shortage status | Resolved |
Updated date | 2022-09-21 |
Company comments | On 100% allocation. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2022-09-21 | French | Compare |
v7 | 2022-09-21 | English | Compare |
v6 | 2022-05-15 | French | Compare |
v5 | 2022-05-15 | English | Compare |
v4 | 2022-03-31 | French | Compare |
v3 | 2022-03-31 | English | Compare |
v2 | 2022-02-08 | French | Compare |
v1 | 2022-02-08 | English | Compare |
Showing 1 to 8 of 8